Analyst Ratings for Ovid Therapeutics Inc (OVID)
OVID Rating Summary
OVID Price Target Summary
- Highest: $7.00 (Oppenheimer)
- Lowest: $1.50 (H.C. Wainwright)
- Average: $4.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$4.50 (+135.6%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/22/2025 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
4.00 (N/A) |
1.47 (1.91) |
29.93% | Details |
| 12/11/2025 | Roth/MKM | Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.57 (1.91) |
21.66% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
